Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tazbentetol
DRUG
2 trials
Sponsors
Spinogenix
Conditions
ALS (Amyotrophic Lateral Sclerosis)
Amyotrophic Lateral Sclerosis
Phase 2
Efficacy and Safety of Tazbentetol in ALS Participants
Not yet recruiting
NCT07325591
Spinogenix
Amyotrophic Lateral Sclerosis
Start: 2026-10-01
End: 2028-03-01
Target: 430
Updated: 2026-09-10
Unknown Phase
Intermediate-size Patient Population Expanded Access Protocol
NCT07088159
Spinogenix
ALS (Amyotrophic Lateral Sclerosis)
Updated: 2026-07-17